Tag: Sunesis Pharmaceuticals

Economy of the United States

Click the tags to see associated articles and topics

View Article Details

Sunesis Pharmaceuticals, Inc. (SNSS) Forms $2.48 Double Bottom; Shufro Rose & Co Has Raised ...

Added to Collection on: 2017-12-10 19:48:45

Tags for this article:

Technology

Qualcomm

NASDAQ

Science and technology in the United States

Click the tags to see associated articles and topics

View Article Details

Sunesis Pharmaceuticals (NASDAQ:SNSS) Stock Rating Lowered by Wells Fargo & Company

Added to Collection on: 2017-12-15 01:03:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Wells Fargo & Co Upgrades Sunesis Pharmaceuticals (NASDAQ:SNSS) to Outperform

Added to Collection on: 2017-12-28 08:10:55

Tags for this article:

Price–earnings ratio

Click the tags to see associated articles and topics

View Article Details

Sunesis Pharmaceuticals (NASDAQ:SNSS) Upgraded by Wells Fargo & Co to Outperform

Added to Collection on: 2018-01-04 08:11:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Traders Purchase High Volume of Sunesis Pharmaceuticals Call Options (NASDAQ:SNSS)

Added to Collection on: 2018-03-09 14:11:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Analysts Set Sunesis Pharmaceuticals (SNSS) PT at $4.49

Added to Collection on: 2018-05-12 01:37:30

Tags for this article:

Infectious causes of cancer

Click the tags to see associated articles and topics

View Article Details

Viracta Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Added to Collection on: 2021-11-10 13:10:39

Tags for this article:

Cancer

Nasopharyngeal carcinoma

Epstein–Barr virus-associated lymphoproliferative diseases

Epstein–Barr virus infection

Valganciclovir